Parameter study of shipping conditions for the ready-to-use application of a 3D human hemicornea construct in drug absorption studies
Beißner N, Zorn-Kruppa M, Reichl S
INT J PHARMACEUT. 2018;536(1):377-387.

Tight Junction barriers in human hair follicles - role of claudin-1
Zorn-Kruppa M, Vidal-Y-Sy S, Houdek P, Wladykowski E, Grzybowski S, Gruber R, Gorzelanny C, Harcup J, Schneider S, Majumdar A, Brandner J
SCI REP-UK. 2018;8:12800.

In vitro eye irritation testing using the open source reconstructed hemicornea - a ring trial
Mewes K, Engelke M, Zorn-Kruppa M, Bartok M, Tandon R, Brandner J, Petersohn D
ALTEX-ALTERN ANIM EX. 2017;34(3):430-434.

Tight Junction Proteins Claudin-1 and Occludin Are Important for Cutaneous Wound Healing
Volksdorf T, Heilmann J, Eming S, Schawjinski K, Zorn-Kruppa M, Ueck C, Vidal-Y-Sy S, Windhorst S, Jücker M, Moll I, Brandner J
AM J PATHOL. 2017;187(6):1301-1312.

The role of tight junctions in skin barrier function and dermal absorption
Bäsler K, Bergmann S, Heisig M, Naegel A, Zorn-Kruppa M, Brandner J
J CONTROL RELEASE. 2016;242:105-118.

Major cell biological parameters of keratinocytes are predetermined by culture medium and donor source
Zorn-Kruppa M, Volksdorf T, Ueck C, Zöller E, Reinshagen K, Ridderbusch I, Bruning G, Houdek P, Moll I, Brandner J
EXP DERMATOL. 2016;25(3):242-4.

Development of an in vitro ocular test system for the prediction of all three GHS categories
Bartok M, Gabel D, Zorn-Kruppa M, Engelke M
TOXICOL IN VITRO. 2015;29(1):72-80.

Epidermal tight junctions in health and disease
Brandner J, Zorn-Kruppa M, Yoshida T, Moll I, Beck L, De Benedetto A
TISSUE BARRIERS. 2015;3(1-2):e974451.

A custom tailored model to investigate skin penetration in porcine skin and its comparison with human skin
Herbig M, Houdek P, Gorissen S, Zorn-Kruppa M, Wladykowski E, Volksdorf T, Grzybowski S, Kolios G, Willers C, Mallwitz H, Moll I, Brandner J
EUR J PHARM BIOPHARM. 2015;95:99-109.

Assessment of the eye irritation potential of chemicals: A comparison study between two test methods based on human 3D hemi-cornea models
Tandon R, Bartok M, Zorn-Kruppa M, Brandner J, Gabel D, Engelke M
TOXICOL IN VITRO. 2015;33(1):561-568.

Determining the Depth of Injury in Bioengineered Tissue Models of Cornea and Conjunctiva for the Prediction of All Three Ocular GHS Categories
Zorn-Kruppa M, Houdek P, Wladykowski E, Engelke M, Bartok M, Mewes K, Moll I, Brandner J
PLOS ONE. 2014;9(12):e114181.

A human hemi-cornea model for eye irritation testing: quality control of production, reliability and predictive capacity
Engelke M, Zorn-Kruppa M, Gabel D, Reisinger K, Rusche B, Mewes K
TOXICOL IN VITRO. 2013;27(1):458-68.

Occludin is involved in adhesion, apoptosis, differentiation and Ca2+-homeostasis of human keratinocytes: implications for tumorigenesis
Rachow S, Zorn-Kruppa M, Ohnemus U, Kirschner N, Vidal Y Sy S, von den Driesch P, Börnchen C, Eberle J, Mildner M, Vettorazzi E, Rosenthal R, Moll I, Brandner J
PLOS ONE. 2013;8(2):e55116.

Prevalidation of a human cornea construct as an alternative to animal corneas for in vitro drug absorption studies.
Hahne M, Zorn-Kruppa M, Guzman G, Brandner J, Haltner-Ukomado E, Wätzig H, Reichl S
J PHARM SCI-US. 2012;101(8):2976-2988.

Letzte Aktualisierung aus dem FIS: 19.04.2024 - 00:43 Uhr